CGAS and autoimmune disease: In contrast, aberrant or excessive activation of the cGAS–STING pathway can cause primary pathogenesis and the manifestation of several autoimmune diseases; thus, identifying compounds, delivery pathways, and treatment regimens targeting the suppression of the cGAS–STING pathway can provide novel approaches to alleviate the symptoms of autoimmune disorders or inflammation.